Close Menu
Invest Intellect
    Facebook X (Twitter) Instagram
    Invest Intellect
    Facebook X (Twitter) Instagram Pinterest
    • Home
    • Commodities
    • Cryptocurrency
    • Fintech
    • Investments
    • Precious Metal
    • Property
    • Stock Market
    Invest Intellect
    Home»Stock Market»Why Are These 4 Dividend Stocks Still Trading At A Deep Discount?
    Stock Market

    Why Are These 4 Dividend Stocks Still Trading At A Deep Discount?

    November 17, 20255 Mins Read


    Business Finance, accounting, contract, advisor investment consulting marketing plan for the company with using tablet and computer technology in analysis.

    Business Finance, accounting, contract, advisor investment consulting marketing plan for the company with using tablet and computer technology in analysis.

    getty

    Will the stock market finish the year higher or lower?

    Who cares?!

    Paying attention to “the market” is a hopeless effort in 2025. The explosion of AI implementation plus the policies from Trump 2.0 are creating winners and losers in the economy.

    So why buy a basket when we can cherry pick the undervalued front runners?

    Even better? Some are cheap! As I write, four big dividend payers (dishing divvies between 5% and 6%) are trading at bargain-basement valuations. Let’s start with the most established of the four-pack, trading for less than its annual sales…

    Cheap Dividend Stock #1: Sonoco Products (SON)

    Sonoco Products (SON) is a packaging dinosaur turned value play. This 126-year-old firm is cheap at 6.5-times earnings, has a 42-year raise streak rolling and is still unloved after a messy Eviosys deal ruffled Wall Street’s feathers.

    The business itself is beautifully boring. Sonoco is a global packaging company that produces both consumer packaging (rigid paper products, steel containers, plastic containers and the like) and industrial packaging (paperboard tubes, protective packaging, recycled paperboards). It also deals in displays and packaging supply-chain services. And thanks to last year’s acquisition of Eviosys, it’s now the world’s largest metal food can and aerosol packaging manufacturer.

    Sonoco yields 5% right now, and the stock is cheap by just about any measure we could want, including forward price-to-earnings (P/E, 6.5), price-to-sales (P/S, 0.7), price-to-cash-flow (P/CF, 7.0) and price/earnings-to-growth (PEG, 0.7) thanks to a sharp pullback:

    Sonoco’s shares have taken several hits over the past couple years, including initial skepticism over the Eviosys deal and high costs and slack demand—the latter two of which contributed to a recent quarterly miss and lowered full-year guidance. Tariffs have also hampered the company more than many expected.

    Still, expectations for both the top and bottom lines are pointed in the right direction, and Sonoco boasts a streak of 42 consecutive increases to its dividend (on an annual basis).

    Cheap Dividend Stock #2: International Paper (IP)

    Another paper giant trading at pulp-level prices, International Paper (IP) fetches just six-times cash flow, pays a 5% yield and is hated enough to be a contrarian setup. IP produces and sells linerboard, whitetop, and saturating kraft paper, among other packaging products. It’s also a major player in pulp, which is used in a variety of personal-care products, construction materials, paints and more.

    IP has suffered similar issues to Sonoco—namely, higher input costs, softer demand, and tariffs. Continued economic uncertainty also doesn’t bode well for the company’s near-term prospects.

    Those headwinds forced International Paper to lower guidance for 2025 and 2026; “Macro conditions in North America and EMEA [Europe, Middle East and Africa] continue to be challenging,” CEO Andy Silvernail said in the post-earnings call.

    A big dip has IP trading at just 6 times cash flows and a PEG of 0.26, not to mention it has raised its payout to nearly 5%. But that’s the only thing bringing up its yield.

    Cheap Dividend Stock #3: Amcor (AMCR)

    Amcor (AMCR) is a 41-year dividend grower hiding in plain sight. Its own merger hangover has the stock cheap while its payout has climbed past 6%.

    Amcor makes a number of food-related packaging products, including high-barrier paperboard trays for beef and meats, glass dressing bottles, overwrap for home and personal care. Its products are also used in garden and outdoor products, agriculture, pet care, healthcare, even building and construction.

    It’s a Dividend Aristocrat with 41 years of dividend growth under its belt. It’s a low-volatility stock, too, with a beta of 0.7 (a beta of less than 1 is considered less volatile than a benchmark; in this case, the S&P 500). And its value metrics are decent to downright attractive, including a P/CF of about 6, forward P/E under 11, and a PEG just slightly below 1. And it now trades at a yield north of 6%.

    Every one of those metrics is better than when we checked in over the summer.

    Amcor has delivered a pair of reports since then, including a lousy final quarter of its fiscal 2025 that showed the company is leaning heavily on synergies from its merger with Berry Corp. to help offset weakness in its legacy divisions, and a lackluster Q1 for its fiscal 2026 in which it met earnings estimates but continued to struggle with weak volumes.

    And unlike many other Aristocrats, its stock price has become somewhat untethered from its dividend growth.

    Cheap Dividend Stock #41: Bristol-Myers Squibb (BMY)

    Bristol-Myers Squibb (BMY, 5.2% yield) is big pharma with a small multiple! It trades under eight-times earnings and pays 5.2% while Wall Street frets over patent cliffs. BMY however boasts a deep stable of more than 30 products that includes cancer treatments Revlimid and Opdivo, and the anticoagulant Eliquis.

    Recently we discussed BMY as one of a few health care stocks that still had a pulse amid a weak year for the sector. The company has since reported an upbeat quarter on the back of strong results for Reblozyl (for anemia due to lower-risk myelodysplastic syndromes) and Camzyos (for symptomatic obstructive hypertrophic cardiomyopathy).

    Partnerships with BioNTech (BNTX) and Bain Capital (BCSF), plus potential blockbuster Opdivo Qvantiq can help soften the blow when Opdivo’s key patent expires in 2028. BMY “pipeline believers” can receive a 5.2% divvie while they wait for this cheap (P/E 8) stock to roll out new pills.

    Brett Owens is Chief Investment Strategist for Contrarian Outlook. For more great income ideas, get your free copy his latest special report: How to Live off Huge Monthly Dividends (up to 7.6%) — Practically Forever.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Stock market today: Dow, S&P 500, Nasdaq retreat as tech leads market lower, banks slide after earnings – Yahoo Finance

    Stock Market

    Stock Markets in 2025: Year of the Reboot

    Stock Market

    6 Ultra-High-Yield Dividend Stocks for Safe Income in 2026 and Beyond

    Stock Market

    Dow, S&P 500, Nasdaq Rise; Nike, DJT, Oracle, Nvidia, Tilray, More Movers

    Stock Market

    How five global cities set the pace for technology in 2025

    Stock Market

    Understanding Proprietary Technology: Types, Benefits, and Examples

    Stock Market
    Leave A Reply Cancel Reply

    Top Picks
    Property

    22 Scariest Haunted Houses in America You Can Actually Visit

    Commodities

    Danske Commodities signe un accord avec le groupe allemand d’achat d’énergie E.optimum

    Cryptocurrency

    India’s CBDC Pilot attracts over 5 million users

    Editors Picks

    Netherlands Commercial Real Estate Outlook 2026 in The Netherlands

    January 7, 2026

    A simple metal could solve the world’s plastic recycling problem

    September 3, 2025

    Coca-Cola Just Recalled Select Cans For Potential Metal Contamination

    October 22, 2025

    IIM-Bangalore launches Fintech Certificate Programme for young professionals | Education News

    August 11, 2025
    What's Hot

    A Digital Yuan on the Global Stage

    August 20, 2025

    Set to Ride on Stablecoin Traction?

    June 17, 2025

    What are Trump’s new ‘Gold’ and ‘Platinum’ visa schemes as H 1B visa fees hiked to $100,000

    September 19, 2025
    Our Picks

    Retirement expert issues warning to every person in their mid-50s

    July 25, 2025

    PB Fintech shares down 9% in two sessions; Here’s what the street is worried about

    December 17, 2025

    Government surplus commodities to be distributed Tuesday in Hays

    May 19, 2025
    Weekly Top

    Fintech investment company swings to profit – The Royal Gazette

    January 28, 2026

    How the Saks Global bankruptcy could affect restaurant real estate

    January 28, 2026

    India Energy Week 2026 Day 2 | GAIL on Hydrogen, Gas Infrastructure & AI-Driven Energy Future

    January 28, 2026
    Editor's Pick

    Exhausted 38-Year-Old Woman Moves into Retirement Home to Slow Down Life Pace

    August 9, 2024

    Property asking prices rise for seventh month in a row

    August 19, 2024

    Dow, S&P 500, Nasdaq futures climb after cooler-than-expected CPI inflation report

    October 24, 2025
    © 2026 Invest Intellect
    • Contact us
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.